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Abstract
Background: With the number of centenarians increasing exponentially in Spain, a deeper knowledge of their
socio-demographic, clinical, and healthcare use characteristics is important to better understand the health profile
of the very elderly.
Methods: We conducted a retrospective, cross-sectional observational study in the EpiChron Cohort (Aragón,
Spain) aimed at analyzing the socio-demographic, clinical, drug use and healthcare use characteristics of 1680
centenarians during 2011–2015, using data from electronic health records and clinical-administrative databases.
Results: Spanish centenarians (79.1% women) had 101.6 years on average. Approximately 80% of centenarians
suffered from multimorbidity, with an average of 4.0 chronic conditions; 50% were exposed to polypharmacy,
with an average of 4.8 medications; only 6% of centenarians were free of chronic diseases and only 7% were
not on medication. Centenarians presented a cardio-cerebrovascular pattern in which hypertension, heart
failure, cerebrovascular disease and dementia were the most frequent conditions. Primary care was the most
frequently visited healthcare level (79% of them), followed by medical specialist consultations (23%),
hospitalizations (13%), and emergency service use (9%).
Conclusions: Multimorbidity is the rule rather than the exception in Spanish centenarians. Addressing medical
care in the very elderly from a holistic geriatric view is critical in order to preserve their health, and avoid the
negative effects of polypharmacy.
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Background
The substantial decline in old age mortality of the
past decades, together with the large birth cohorts
of the early 1900s, has led to more and more
people currently living beyond 100 years worldwide
[1]. The United Nations, which monitors the global
number of centenarians since 1990, stated that this
age group will strongly increase from half a million
in 2015 to more than 25 million people in 2100 [2].
In Spain, their numbers are estimated to increase
from 16,460 at present to more than 220,000 in
2066 [3].
Additionally, the rates of multimorbidity (i.e., pres-
ence of two or more chronic diseases) [4] and of its
associated negative consequences such as higher risk
of polypharmacy, disability and functional decline, and
inappropriate healthcare use (e.g., hospitalizations by
ambulatory care sensitive conditions, readmissions to
hospital in a short period of time, overutilization of
healthcare services) [5] could be expected to increase
in centenarians as the burden of chronic diseases
consistently grows with age [6–8]. Notwithstanding,
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centenarians have been described as a heterogeneous
population group in terms of their morbidity profiles
[9, 10] and health service use patterns [11], which
might be explained in part by the dissimilar popula-
tions and methodologies used in the existing literature
[12–14].
Some studies suggest that the burden of chronic con-
ditions in centenarians is low, with low lethality rates
[10, 15, 16] and low healthcare use [17]. Richmond et al.
[16] conducted a study based on structured health
history questionnaires and reported a relatively low
prevalence of chronic conditions, with many centenar-
ians escaping cardiovascular disease, osteoporosis,
dementia, respiratory illness, cancer, anxiety and depres-
sion. However, the positive results reported by Austra-
lian centenarians might be related in part to the fact that
this study was based on self-perceived health informa-
tion from a convenience sample with various recruit-
ment methods. By contrast, the Danish Centenarian
Study [9] showed high levels of morbidity, particularly in
hypertension (52%), dementia (51%), ischemic heart dis-
ease (27%), and strokes (22%); and a study of Tokyoite
centenarians [18] found that more than 95% of them
had chronic diseases.
The most commonly reported diseases in centenar-
ians vary among studies and countries, including
chronic conditions and symptoms such as joint pain
(64%), hypertension (40–64%), cataracts/ocular disease
(47–71%), arthritis (58%), left ventricular dysfunction
(54%), heart disease (29–31%), osteoporosis (28%),
gastrointestinal disease (21%), depression (18%), and
cerebrovascular disease (16%), and also conditions such
as fractures (47%) and dizziness (44%) [16, 18, 19].
Understanding the health profile and health care
needs of the very elderly and generally frail, such as
centenarians, becomes especially relevant when consid-
ering their numbers are increasing exponentially. Al-
though the more methodologically sound research
studies reported high prevalence of chronic diseases
and multimorbidity in centenarians, no studies on the
health status or healthcare use of Spanish centenarians
have been published in the English literature. With our
data including almost all centenarians in a geographical
region that is representative of the whole of Spain we
expect to provide sound scientific knowledge to this
field of study. This could facilitate the design of specific
care models fitting the socio-demographic and clinical
characteristics of centenarians, and the identification of
potential underlying factors for shorter longevity. The
aim of this study was to describe the socio-demo-
graphic, clinical and healthcare use characteristics of a
cohort of Spanish centenarians using routinely col-
lected data from electronic health records and clinical-
administrative databases.
Methods
Design and study population
We conducted a retrospective, cross-sectional obser-
vational study in the EpiChron Cohort [20]. This co-
hort links socio-demographic, clinical, health services
use, and drug dispensation information for the public
health system users of the Spanish region of Aragón
(1.3 million inhabitants). The reference population of
the EpiChron Cohort was 1,253,292 individuals at
baseline (i.e., January 1, 2011), which represents ap-
proximately 98% of total inhabitants. The study popu-
lation was composed of people from the cohort aged
100 years or more who were alive at some point in
time from January 1, 2011 to December 31, 2015.
The anonymized data used in the study was obtained
from electronic health records and clinical-administra-
tive databases linked at the patient level (i.e., user
database, primary, specialist, hospital and emergency
care, and pharmacy billing databases). A more de-
tailed description of the cohort profile and of the data
sources has been published elsewhere [20]. Only pa-
tients with at least one contact with the health system
registered in their electronic health records were in-
cluded in the study (Fig. 1).
The information analyzed included age, sex, area of resi-
dence (urban/rural), deprivation index of the area (accord-
ing to 26 socioeconomic indicators) [21], all diagnoses of
chronic diseases, all chronic medications dispensed, use of
potentially inappropriate medications according to the up-
dated Beers criteria [22], and healthcare use rates. All the
information analyzed corresponded to the last 365 days of
follow-up of each participant, which ended with either
death of the patient, withdrawal of the system, or on
December 31, 2015. Diagnoses were grouped in Expanded
Diagnostic Clusters (EDCs) based on the Johns Hopkins
ACG® System (version 11.0, The Johns Hopkins University,
Baltimore, MD, US). This classification system is useful in
multimorbidity studies to count diseases when diagnoses
from different sources and codification systems are used
(e.g., ICPC-1 codes from primary care and ICD-9-CM
codes from hospitals). For the analysis of multimorbidity,
defined as the co-occurrence of two or more chronic dis-
eases, we considered all 114 of the EDCs defined as chronic
by Salisbury et al. [23]. We defined chronic medications as
those with three or more dispensations over the 365-days
follow-up period, using the Anatomical-Therapeutic-
Chemical (ATC) classification system code at the third
level. We calculated the anticholinergic drug scale score
[24] and the anticholinergic cognitive burden [25] for each
patient based on their medical prescriptions.
Statistical analysis
We performed a descriptive analysis of socio-demographic,
clinical, healthcare use and drug use characteristics of
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centenarians, by sex. The results were calculated as
means and/or frequencies accompanied by their 95%
confidence intervals. We used the Kruskal-Wallis test
to compare means and the Pearson’s chi-squared test
to compare frequencies. Statistical significance was
set at p < 0.05. We conducted all the analyses in
Stata (Version 12.0, StataCorp LLC, College Station,
TX, US).
Results
Demographics of centenarians
A total of 1680 people (79.1% women) of the Epi-
Chron Cohort were 100 years old or above at some
point in time from January 1, 2011 to December 31,
2015 and had valid electronic health records. Their
socio-demographic characteristics are shown in
Table 1. They had an average age of 101.6 (standard
deviation, s.d., 1.84) years, with no differences by sex.
The maximum age registered was 111 years in women
and 109 years in men. Two women were supercente-
narians (i.e., 110 years old or older), and 32 men and
101 female were semi-supercentenarians (i.e., aged
105 years or more). Regarding their place of residence,
57% of centenarians lived in an urban area during the
study period. Approximately 30% of them lived in the
less deprived areas (i.e., Q1) according to the
deprivation index calculated for each basic health area
of the region.
Disease burden in centenarians
Centenarians showed an average disease burden of al-
most 4 chronic conditions with no differences by sex,
and approximately 6% of them did not present any
chronic condition (Table 1). The prevalence of multi-
morbidity reached 80% of the centenarian population.
The ten most frequently reported chronic conditions
in centenarians were, regardless of their sex, hyperten-
sion (56.0%), chronic ulcer of skin (28.1%), cerebrovascu-
lar disease (21.5%), congestive heart failure (20.3%),
dementia (19.9%), degenerative joint disease (17.1%),
varicose veins of lower extremities (14.9%), cataract/
aphakia (13.9%), cardiac arrhythmia (11.7%), and dia-
betes (11.1%; Table 2). Incontinence was present in
49.5% of centenarians. The prevalence of some cardio-
vascular risk factors, such as hypertension and lipid
metabolism disorders, as of other conditions such as
chronic ulcer of the skin, dementia, degenerative joint
disease, varicose veins, and osteoporosis was higher in
women. On the other hand, men showed higher preva-
lence rates of COPD, other respiratory disorders, gout,
and low back pain.
Drug use in centenarians
Centenarians presented a mean treatment burden of 4.8
chronic medications (Table 1), and 49.5% of them re-
ceived five or more drugs (i.e., polypharmacy). Only 7%
of centenarians had no chronic medications dispensed.
According to the updated Beers criteria from 2015 [22]
and to anticholinergic scores [24], centenarians received
on average 1.35 potentially inappropriate medications,
8% of them were treated with high anticholinergic risk
drugs, and 11% suffered a high anticholinergic cognitive
burden, with no differences by sex.
Gastroprotective drugs (50.9%), antithrombotic agents
(40.6%), analgesics and antipyretics (36.0%), diuretics
(34.2%), anxiolytics (21.5%), antidepressants (14.4%),
hypnotics-sedatives (13.8%), antipsychotics (13.6%), and
ACE (angiotensin converting enzyme) inhibitors (13.4%)
were the most frequently dispensed chronic drugs in
centenarians (Table 3). The dispensation of anxiolytics,
hypnotics-sedatives, and opioids, among others, was
Fig. 1 Flowchart for the study population
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Table 1 Socio-demographic, clinical and healthcare use characteristics of centenarians, by sex. Means are accompanied by their 95%
confidence intervals in brackets
Men Women P value
Socio-demographics
N 351 1329 <0.001
Mean age, yearsa 101.7 (101.5–101.9) 101.6 (101.5–101.7) n.s.b
Urban residence, % 58.7% 56.7% n.s.
Deprivation index, %c n.s.
Q1 29.1% 31.1%
Q2 23.7% 22.8%
Q3 24.0% 20.7%
Q4 23.1% 25.6%
Clinical information
Without chronic diseases, % 7.6% 5.2% n.s.
Chronic diseases, meana 3.97 (3.65–4.28) 3.97 (3.81–4.12) n.s.
With multimorbidity, % 78.0% 81.3% n.s.
Without chronic medications, % 8.1% 6.4% n.s.
Chronic drugs, meana 4.94 (4.56–5.33) 4.77 (4.58–4.95) n.s.
With polypharmacy, %d 49.8% 49.5% n.s.
With potentially inappropriate medications, %a,e 71.1% 72.3% n.s.
Potentially inappropriate medications, meana 1.32 (1.19–1.45) 1.36 (1.29–1.43) n.s.
Anticholinergic Drug Scale score, % n.s.
0 50.6% 50.2%
1 28.2% 29.5%
2 12.4% 12.3%
≥3 8.8% 8.0%
Anticholinergic Cognitive Burden score, % n.s.
0 55.3% 52.3%
1 26.0% 28.8%
2 6.2% 8.5%
≥3 12.5% 10.4%
Healthcare use
Users of primary care services, % 76.1% 79.4% n.s.
Visits to GPf, meana 10.6 (9.4–11.7) 10.8 (10.2–11.5) n.s.
Visits to nurse, meana 9.3 (7.8–10.9) 12.1 (10.9–13.3) n.s.
Users of specialities, % 24.5% 22.3% n.s.
Visits to a specialist, meana 2.79 (2.16–3.43) 2.72 (2.44–2.99) n.s.
Different specialties visited, meana 1.37 (1.23–1.51) 1.47 (1.37–1.57) n.s.
Users of hospital, % 14.8% 12.1% n.s.
Total hospital admissions, meana 1.35 (1.17–1.52) 1.34 (1.23–1.45) n.s.
Scheduled hospital admissions, meana 0.06 (0.00–0.12) 0.12 (0.06–0.17) n.s.
Length of stay in days, meana 10.0 (7.9–12.0) 11.6 (10.3–13.0) n.s.
Users of emergency room, % 11.7% 8.3% n.s.
Visits to emergency room, meana 1.80 (1.40–2.21) 1.45 (1.28–1.62) n.s.
aA non-parametric test was used; bNot statistically significant; cFrom less (Q1) to most (Q4) deprived administrative health areas; dDefined as five or more drugs
dispensed; eAccording to Beers criteria; fGeneral Practitioner
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Table 2 Prevalence of chronic conditions in men (n = 351) and women (n = 1329) centenarians. Conditions are listed in descending
order of total prevalence, and only those with prevalence equal to or greater than 1% are represented
EDCa code Chronic condition Men (%) Women (%) P value
CAR14/15 Hypertension 46.8 58.4 <0.001
REC03 Chronic ulcer of the skin 22.0 29.7 <0.01
NUR05 Cerebrovascular disease 22.3 21.3 n.s.b
CAR05 Congestive heart failure 20.2 20.3 n.s.
NUR24 Dementia 12.8 21.7 <0.001
MUS03 Degenerative joint disease 13.2 18.1 <0.05
GSU08 Varicose veins of lower extremities 8.6 16.5 <0.001
EYE06 Cataract, aphakia 14.7 13.7 n.s.
CAR09 Cardiac arrhythmia 14.1 11.1 n.s.
END06/07/08/09 Diabetes 10.1 11.4 n.s.
EAR08 Deafness, hearing loss 8.6 10.9 n.s.
CAR11 Disorders of lipid metabolism 6.4 11.4 < 0.05
PSY19 Sleep disorders of nonorganic origin 8.9 10.8 n.s.
HEM02 Iron deficiency, other deficiency anemias 11.9 9.7 n.s.
EYE08 Ischemic heart disease or AMIc 11.6 9.1 n.s.
PSY09 Glaucoma 8.0 8.9 n.s.
END02 Depression 7.3 8.2 n.s.
CAR03 Osteoporosis 1.8 9.3 <0.001
RES04 Emphysema, chronic bronchitis, COPDd 14.7 5.4 <0.001
SKN02 Dermatitis and eczema 8.6 6.1 n.s.
HEM03 Malignant neoplasms 9.7 4.3 <0.001
NUR21 Thrombophlebitis 3.4 5.8 n.s.
GUR04 Neurologic disorders, other 5.8 5.0 n.s.
RES11 Prostatic hypertrophy 24.2 0.0 <0.001
EYE02 Respiratory disorders, other 7.0 4.2 <0.05
MAL01 Visual impairment 5.5 4.6 n.s.
CAR16 Skin/low impact neoplasms 5.5 3.8 n.s.
END04 Cardiovascular disorders, other 3.1 3.9 n.s.
END05 Hypothyroidism 3.1 3.8 n.s.
REN01 Other endocrine disorders 1.8 4.1 n.s.
RHU02 Chronic renal failure 4.9 3.0 n.s.
NUT03 Gout 7.0 2.1 <0.001
ADM02 Obesity 1.5 3.5 n.s.
CAR12 Surgical aftercare 3.4 2.8 n.s.
HEM08 Hematologic disorders, other 4.3 2.4 n.s.
ALL04/05 Asthma 1.5 3.1 n.s.
GAS10 Diverticular disease of colon 2.5 1.9 n.s.
PSY14 Psychosocial disorders of childhood 1.2 2.2 n.s.
PSY01 Anxiety, neuroses 1.2 2.0 n.s.
CAR06 Cardiac valve disorders 1.8 1.8 n.s.
MAL12 Low back pain 3.1 1.0 <0.05
MUS14 Irritable bowel syndrome 0.9 1.3 n.s.
GAS09 Seizure disorder 2.1 1.0 n.s.
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higher in women compared with men; whereas the latter
were prescribed more non-steroidal anti-inflammatory
and antirheumatic products, antigout preparations, and
inhalants for obstructive airway diseases and adrenergics.
Healthcare use of centenarians
Primary care was the most frequently visited level of
care by centenarians. It was used by 79% of them, with
an average of 11 annual visits to the General Practitioner
(GP) and to the nurse (Table 1). Specialists were less fre-
quently visited, and only 23% of centenarians received
specialized care, with an average of 2.7 visits per year to
1.5 different specialities. The most visited specialists
were radiologists (56.6% of the visits to a specialist), oph-
thalmologists (9.3%), orthopaedists and traumatologists
(5.1%), dermatologists (4.4%), cardiologists (3.5%), and
endocrinologists, nutritionists and urologists (2.3%),
among others. More than 85% of centenarians did not
require hospitalization during the study period. Those
that used hospital care were admitted 1.3 times per year
on average with a mean length of stay of 11 days. Un-
planned hospitalizations were much more frequent than
scheduled ones and represented 92.5% of the total num-
ber of hospitalizations. The ten most prevalent reasons
for hospital admission were heart failure (in 12.0% of
admissions), femoral neck fractures (10.0%), other re-
spiratory system diseases (9.4%), pneumonia (6.5%),
occlusion of cerebral arteries (3.5%), other lung diseases
(3.5%), pneumonitis due to solids and liquids (3.3%),
septicaemia (2.5%), acute renal failure (2.2%), and other
urethral and urinary tract disorders (2.0%). Approxi-
mately nine in ten centenarians did not require visiting
the emergency room; the rest visited this service 1.5
times per year on average. Sex had no effect on the
utilization of any healthcare service.
Discussion
This study describes the socio-demographic, clinical and
healthcare use characteristics of 1680 Spanish centenar-
ians of the EpiChron Cohort between 2011 and 2015
based on electronic health records and clinical-adminis-
trative data sources. As far as we know, this is the first
study describing the health status of Spanish centenar-
ians in the English literature using register-based health
record data from a population-based cohort. As ex-
pected, the vast majority of people who reached age 100
were women [26].
Multimorbidity prevalence has been shown to increase
as we get older [23, 27]. This concurs with the results
from the EpiChron Cohort, where multimorbidity preva-
lence increased from 12% in the population aged 0–14
years to 16, 47, and 80% in people aged 15–44, 45–64
and ≥ 65 years, respectively [20]. According to this trend,
one might have expected multimorbidity prevalence in
centenarian populations to be above the 80% observed
in the present study. However, our results do not neces-
sarily indicate a lower-than-expected burden of chronic
diseases, and could just signify physical and/or environ-
mental difficulties in accessing health care services, or a
‘laissez-faire’ attitude or ageism [28] that could ultim-
ately result in lower diagnosis rates.
Medical literature regarding the prevalence of cente-
narians without a diagnosis of common chronic condi-
tions is inconsistent. In the Danish Centenarian Study
[9] the authors found that only one out of 207 subjects
was free of actual diseases or chronic conditions. A
Japanese study found it to be less than 3% [18], another
study reported that 19% of centenarians did not present
chronic diseases [10], and yet another study found that
23% of centenarians reached age 100 with no major
chronic diseases [29]. The proportion of disease-free
centenarians in our study (6%) is within this range,
nonetheless, these figures should be interpreted with
caution, since previous studies apply varying methodolo-
gies and approach sample recruitment and condition
analysis differently. In our study, we used a comprehen-
sive list of more than 100 diseases, in contrast with the
lists used by other authors [10, 29]. Additionally, data
sources were of great importance when interpreting the
results. Electronic health records offered an objective
method of patient clinical characterization through the
diagnosis of previously confirmed medical conditions by
healthcare professionals. Nevertheless, although the pub-
lic health system in Spain provides universal coverage,
the absence of registered clinical information does not
necessarily mean an absence of disease. Furthermore,
health care service use for diagnostic or therapeutic
purposes may have been rejected by a number of
Table 2 Prevalence of chronic conditions in men (n = 351) and women (n = 1329) centenarians. Conditions are listed in descending
order of total prevalence, and only those with prevalence equal to or greater than 1% are represented (Continued)
EDCa code Chronic condition Men (%) Women (%) P value
NUR07 Utero-vaginal prolapse 0.0 1.4 <0.05
FRE12 Parkinson’s disease 1.5 1.0 n.s.
NUR06 Gastroesophageal reflux 0.6 1.2 n.s.
GAS08 Peripheral neuropathy, neuritis 0.6 1.2 n.s.
aFrom a list of 114 Expanded Diagnostic Clusters; bNot statistically significant; cAcute myocardial infarction; dChronic obstructive pulmonary disease
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Table 3 Prevalence of most dispensed chronic medications in men (n = 351) and women (n = 1329) centenarians. Drugs are listed
in descending order of total prevalence, and only those with prevalence equal to or greater than 1% are represented
ATCa code Chronic medication Men (%) Women (%) P value
A02B Drugs for peptic ulcer and GERDb 53.9 50.2 n.s.c
B01A Antithrombotic agents 43.6 39.9 n.s.
N02B Other analgesics and antipyretics 34.1 36.4 n.s.
C03C High-ceiling diuretics 31.5 34.9 n.s.
N05B Anxiolytics 13.9 23.4 <0.001
N06A Antidepressants 12.8 14.7 n.s.
N05C Hypnotics and sedatives 9.9 14.7 <0.05
N05A Antipsychotics 11.4 14.2 n.s.
C09A ACEd inhibitors, plain 7.3 14.9 <0.001
B03A Iron preparations 12.8 10.7 n.s.
C08C Selective calcium channel blockers with mainly vascular effects 13.9 10.3 n.s.
C05C Capillary stabilizing agents 4.4 11.4 <0.05
C01D Vasodilators used in cardiac diseases 8.1 10.3 n.s.
C09C Angiotensin II receptor blockers, plain 7.0 9.0 n.s.
M02A Topical products for joint and muscular pain 6.1 9.0 n.s.
C09D Angiotensin II receptor blockers, combinations 5.9 8.4 n.s.
S01E Antiglaucoma preparations and miotics 7.7 7.3 n.s.
A06A drugs for constipation 8.1 6.7 n.s.
M01A Antiinflammatory and antirheumatic products, non-steroids 10.3 6.1 <0.05
C01A Cardiac glycosides 8.1 6.6 n.s.
N06B Psychostimulants, agents used for ADHDe and nootropics 8.8 6.0 n.s.
R05C Expectorants, excl. Combinations with cough suppressants 8.4 5.5 n.s.
A10B Blood glucose lowering drugs, excl. Insulins 5.1 5.9 n.s.
V06X General nutrients 5.5 5.6 n.s.
B03B Vitamin B12 and folic acid 5.1 5.5 n.s.
C07A Beta blocking agents 4.4 5.7 n.s.
N02A Opioids 2.2 6.2 <0.05
G04C Drugs used in benign prostatic hypertrophy 26.0 0.0 <0.001
C10A Lipid modifying agents, plain 6.6 4.3 n.s.
C04A Peripheral vasodilators 5.5 4.1 n.s.
R03A Adrenergics, inhalants 7.3 3.7 <0.05
R03B Other drugs for obstructive airway diseases, inhalants 7.3 3.7 <0.05
S01X Other ophthalmologicals 3.7 4.4 n.s.
C09B ACE inhibitors, combinations 3.7 4.3 n.s.
D01A Antifungals for topical use 4.0 4.2 n.s.
C03D Potassium-sparing agents 5.9 3.6 n.s.
C03E Diuretics and potassium-sparing agents in combination 1.1 4.6 <0.05
A03F Propulsives 1.1 4.1 <0.05
R06A Antihistamines for systemic use 5.5 3.1 n.s.
C01E Other cardiac preparations 3.7 3.4 n.s.
C03B Low-ceiling diuretics, excl. Thiazides 2.6 3.6 n.s.
C08D Selective calcium channel blockers with direct cardiac effects 3.7 2.7 n.s.
A12A Calcium 0.7 3.3 <0.05
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centenarians. In the Danish Centenarian Study [9] all
participants (including proxies) were visited at their
domicile for an interview, and further health information
was retrieved from medical files and national health
registers.
The most frequent diseases observed in centenar-
ians vary among studies. The high prevalence of car-
diovascular diseases found in our study is, however, a
common finding, and has also been reported in 72
and 40% of Danish and New England centenarians,
respectively [9, 10]. Some of the diseases from the
cardio-cerebrovascular disease pattern showed by our
centenarians (i.e., hypertension, heart failure, cerebro-
vascular disease, and cardiac arrhythmia) have also
been reported in other studies as the most prevalent
in this age group. Hypertension prevalence was
similar in Spanish, Danish and Japanese centenarians
[9, 18], while heart failure prevalence was lower in
our study compared to that reported by Danish and
Canadians [9, 17]. Cardiovascular and cerebrovascular
diseases are the only frequent conditions in our study
that associate high mortality rates [10, 15]. The preva-
lence of diabetes mellitus in our centenarians (11%) was
similar to the 6–10% reported by other authors despite
using different methodologies [9, 10, 18]. High dementia
prevalence is also a common finding in centenarians [30],
especially in women [17], whereas chronic ulcers of the
skin are more likely to be a consequence of prolonged lim-
itations in mobility as a result of underlining disorders.
According to our findings, one in two centenarians
was polymedicated. The most frequently dispensed
medications were similar to those in a Swedish study of
community dwelling centenarians [31]. The proportion
of individuals in our study with no drug prescriptions
(7%) was similar to the 5% found in the Danish Study
[9]. A study conducted in the United Kingdom (UK),
with an observation period of over twenty years using a
Primary Care database of 11,000 individuals who
reached the age of 100, reported that 27% of centenar-
ians had no drug prescriptions [32]. The mean burden
of treatment in our centenarians, however, was lower,
maybe because we only included chronic medication. It
is also worth noting that our centenarians were treated
with drugs with a low anticholinergic load. Despite all
that, the percentage of individuals receiving inappropri-
ate medication according to the Beers criteria was
double when comparing with the UK study [32].
Some of the differences between men and women in
our results regarding drug dispensation could be reason-
ably attributed to gender-related morbidities, while
others could suggest unequal treatment of specific con-
ditions (i.e., gender inequalities) [33]. For example, the
overprescription of certain drugs, such as anxiolytics and
hypnotics, was greater in women than in men, even
Table 3 Prevalence of most dispensed chronic medications in men (n = 351) and women (n = 1329) centenarians. Drugs are listed
in descending order of total prevalence, and only those with prevalence equal to or greater than 1% are represented (Continued)
ATCa code Chronic medication Men (%) Women (%) P value
A12B Potassium 1.8 3.1 n.s.
D07A Corticosteroids, plain 4.8 2.3 <0.05
M04A Antigout preparations 5.9 2.0 <0.001
N03A Antiepileptics 1.8 3.0 n.s.
N07C Antivertigo preparations 2.9 2.6 n.s.
J01 M Quinolone antibacterials 4.0 1.9 n.s.
H02A Corticosteroids for systemic use, plain 3.7 1.7 n.s.
H03A Thyroid preparations 1.1 2.3 n.s.
J01X Other antibacterials 2.9 1.4 n.s.
J01C Beta-lactam antibacterials, penicillins 2.6 1.4 n.s.
N06D Anti-dementia drugs 1.8 1.6 n.s.
V06Z General nutrients 2.9 1.4 n.s.
S01A Antiinfectives 0.7 1.7 n.s.
A10A Insulins and analogues 1.5 1.4 n.s.
C03A Low-ceiling diuretics, thiazides 0.7 1.4 n.s.
J01D Other beta-lactam antibacterials 1.1 1.4 n.s.
R05D Cough suppressants, excl. Combinations with expectorants 2.3 1.0 n.s.
H03B Antithyroid preparations 0.7 1.1 n.s.
aAnatomical Therapeutic Chemical Classification System; bGastroesophageal reflux disease; cNot statistically significant; dAngiotensin-converting-enzyme;
eAttention deficit hyperactivity disorder
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though there were no significant differences in the
prevalence of sleep disorders or anxiety/neuroses when
stratifying by sex. Similarly, women were more often
treated for pain with stronger analgesics, like opioids,
when comparing with men.
Healthcare use in centenarians was lower than ex-
pected by age regardless of the level of care analyzed.
The relatively low burden of chronic diseases and medi-
cations in centenarians resulted, as expected, in less
intensive use of medical services [34]. These findings
could even suggest a more appropriate pattern of health-
care use in centenarians, who mainly resorted to primary
care instead of specialized care, and were not frequent
users of emergency services. Our results are similar to
those found in a previous study based on administrative
health data of 1842 Canadian centenarians, who used
primary care, hospital care and emergency services in
95, 18 and 26% of cases, respectively [17]. However,
these results should be interpreted with caution as they
might be explained in part by physical and/or environ-
mental difficulties faced by these patients in accessing
health care services.
Strengths and limitations of the study
The main strength of this study is that it draws on a
population-based cohort representative of the Span-
ish population, although only users of the public
health system with available electronic health re-
cords were considered for inclusion. As our main
limitation, data used in the study was anonymized
and centenarians could not be contacted to collect
extra variables related to longevity that could have
been of interest for the purposes of this study, such
as lifestyle habits (e.g., smoking habit, alcohol con-
sumption), level of physical functioning (e.g., activ-
ities of daily living), and biological, educational, and
socioeconomic (e.g., housing conditions) indicators.
Instead, data came from electronic health records
and clinical-administrative databases, which, while
constituting primary sources of clinical information,
were not primarily designed for research purposes
and, consequently, could entail some errors during
the registration process.
Conclusions
The utilization of electronic health records allowed
for the characterization of the health profile and
healthcare use of Spanish centenarians. Multimorbid-
ity seems to be the rule rather than the exception in
this population, which mainly presented a cardio-cere-
brovascular pattern including hypertension, heart fail-
ure, cerebrovascular disease, dementia, and skin
ulcers. Addressing medical care in the very elderly
from a holistic geriatric view is critical in order to
preserve their health, and avoid the negative effects of
polypharmacy. Future studies aimed at characterizing
the health profile and longevity determinants of
centenarians should also take into account genetic,
environmental and socioeconomic factors as well as
lifestyle habits and physical functionality.
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